TerminatedPhase 4NCT03866538
Budesonide in Patients With Immune Mediated Enteropathies
Studying Severe immune-mediated enteropathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Joseph A Murray, MDMayo Clinic
- Intervention
- Withdrawal of Oral Budesonide(drug)
- Enrollment
- 1 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2019 – 2021
Study locations (1)
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03866538 on ClinicalTrials.gov